pH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review)

Inflammatory bowel diseases (IBD) have developed to become a major global health problem. Ulcerative colitis (UC) is one of two main types of IBD, and >90% of patients suffering from mild or moderate forms of UC are treated with mesalazine, a well-tolerated and cost-effective drug. To allow oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Deissler, Helmut, Krammer, Heinrich, Gillessen, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493545/
https://www.ncbi.nlm.nih.gov/pubmed/34631051
http://dx.doi.org/10.3892/br.2021.1472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493545/
https://www.ncbi.nlm.nih.gov/pubmed/34631051
http://dx.doi.org/10.3892/br.2021.1472

Ejemplares similares